Answers are grounded in this paper and cite their sources.
Preliminary findings show high acceptability of electronic consenting among patients with cancer, indicating potential to enhance traditional consent methods.
Background Informed consent is essential to ensuring ethical conduct of clinical research in oncology, but can be challenging and time-consuming to implement. Electronic consenting (e-consent) may address these issues, but acceptability of e-consent among patients with cancer must be assessed. Methods An asynchronous preliminary e-consent was developed for a prospective circulating tumor DNA testing study for patients with colorectal/pancreatic cancer. Following e-consent, patient satisfaction was assessed in a follow-up call before full consent was obtained. Acceptability was assessed with descriptive statistics and bivariate analysis. Results Fifty-one participants completed the preliminary e-consent, 90% of which preferred electronic full consent over traditional consent. Comfort enrolling after e-consent was rated highly by 93% of participants. Additionally, 80% of participants indicated that a follow-up call had no impact on decision to enroll. Conclusion These findings suggest that asynchronous e-consenting is highly acceptable among oncology patients but future work should assess comprehension with this approach.
No takes yet. Share an insight, caveat, or question.
Chia et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: